Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference
Sutro Biopharma announced its participation in the 17th Annual World ADC Conference in San Diego, October 12-15, 2026. The company will present early clinical safety and pharmacokinetic data on STRO-004, plus preclinical insights on STRO-006 and its first wholly-owned dual-payload ADC, STRO-227.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.